MedTrace Logo

Robotic Versus Conventional Training on Hemiplegic Gait.

NCT01187277 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-07-17

No results posted yet for this study

Summary

The incidence of stroke in the industrial world is still high. Most of the patients are suffering from paresis of the affected side, speech and cognition problems. Modern concepts of motor learning after stroke favouring a task-specific repetitive high-intensity therapy approach to promote motor outcome. In the last couple of years robot-assisted therapy became an important part of modern rehabilitation after stroke. But so far there is no clear evidence that robot assisted therapy in combination with conventional therapy is more effective than conventional therapy alone to promote motor functions after stroke.

Conditions

Interventions

BEHAVIORAL

conventional therapy

conventional therapy means: 50 min individual physiotherapy and 60 min individual occupational therapy per work day (5x per week)for four consecutive weeks

DEVICE

conventional plus robotic gait assisted therapy

individual physiotherapy +individual occupational therapy+ robotic gait assisted therapy

Sponsors & Collaborators

  • Mahidol University

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Prasat Neurological Institute

    lead OTHER_GOV

Principal Investigators

  • Ratanapat Chanubol, M.D. · Rehabilitation department, Prasat Neurological Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-05-31
Completion
2012-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01187277 on ClinicalTrials.gov